chromium has been researched along with Coronary Stenosis in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (10.53) | 29.6817 |
| 2010's | 15 (78.95) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Aoki, J; Awata, M; Kashiwabara, K; Kimura, T; Kozuma, K; Matsuyama, Y; Nanasato, M; Oba, K; Shinozaki, T; Shiode, N; Tanabe, K; Yamaguchi, J | 1 |
| Asano, T; Chichareon, P; Digne, F; Gil, RJ; Kogame, N; Lefèvre, T; Legutko, J; Modolo, R; Morel, MA; Onuma, Y; Serruys, PW | 1 |
| Angiolillo, DJ; Baber, U; Bangalore, S; Bhatt, DL; Chandiramani, R; Claessen, BE; Ge, J; Guedeney, P; Hermiller, J; Kozuma, K; Krucoff, M; Liu, Y; Makkar, R; Mehran, R; Neumann, FJ; Rau, V; Saito, S; Seth, A; Sorrentino, S; Valgimigli, M; Vogel, B; Wang, J | 1 |
| Bil, J; Gil, RJ; Kern, A; Pawłowski, T | 1 |
| Folgado, J; Ribeiro, NS; Rodrigues, HC | 1 |
| Bil, J; Gąsior, M; Gil, RJ; Kern, A; Legutko, J; Lesiak, M; Pawłowski, T; Witkowski, A | 1 |
| Allocco, DJ; Calabria, P; Capodanno, D; Crowley, JJ; Dawkins, KD; Erglis, A; Gilbert, TJ; Horváth, IG; Menown, IB; Moreno, R; Tamburino, C | 1 |
| Allocco, DJ; Carrié, D; Erglis, A; Hamm, CW; Masotti, M; Mego, D; Underwood, P; Wang, JC; Watkins, MW | 1 |
| Goto, K; Hagikura, A; Haruta, S; Takebayashi, H | 1 |
| Arokiaraj, MC; De Beule, M; De Santis, G; Palacios, IF | 1 |
| Hirohata, A; Kataoka, K; Kimura, T; Kozuma, K; Morino, Y; Tanabe, K; Tobaru, T; Yasuda, S | 1 |
| Arana, C; Dager, A; Delgado, JA; Gasior, P; Généreux, P; Granada, JF; Hernandez, H; Higuera, S; Maehara, A; Moncada, M; Vesga, B | 1 |
| de Winter, RJ; Dijkstra, J; Kimura, T; Kozuma, K; Miyazaki, Y; Onuma, Y; Popma, JJ; Serruys, PW; Sotomi, Y; Tanabe, K | 1 |
| Ball, MW; Bertolet, B; Cannon, LA; Dauber, IM; Dawkins, KD; Feldman, RL; Foster, MC; Kabour, A; Kereiakes, DJ; Magorien, R; Popma, JJ; Rabinowitz, AC; Underwood, P; Wang, JC; Whitbourn, R | 1 |
| Allocco, DJ; Dawkins, KD; El-Jack, S; Meredith, IT; Scott, D; Starzyk, RM; Stone, GW; Teirstein, PS; Whitbourn, R; Zambahari, R | 1 |
| Cha, KS; Chae, IH; Hwang, KK; Jeon, HK; Jeong, MH; Kang, SH; Kim, HS; Kim, S; Kwon, HM; Lee, SP; Lee, SY; Moon, KW; Oh, JH; Park, BE; Park, JJ; Park, KW; Park, TH; Rhew, JY; Shin, ES; Yoon, JH | 1 |
| Anisimowicz, L; Pawliszak, W; Serafin, Z; Sukiennik, A | 1 |
| Bhargava, B; Karthikeyan, G; Mishra, S; Raju, R; Reddy, NK; Singh, S; Somaraju, B; Virmani, R; Waksman, R | 1 |
| Buszman, P; Kinasz, L; Kondys, M; Król, M; Milewski, K; Trznadel, S; Zurakowski, A | 1 |
6 trial(s) available for chromium and Coronary Stenosis
| Article | Year |
|---|---|
Treatment with a dedicated bifurcation sirolimus-eluting cobalt-chromium stent for distal left main coronary artery disease: rationale and design of the POLBOS LM study.
Topics: Chromium; Cobalt; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Drug-Eluting Stents; Humans; Percutaneous Coronary Intervention; Prospective Studies; Prosthesis Design; Sirolimus; Stents; Treatment Outcome | 2020 |
Rationale and design of the randomized, multicenter, open-label, controlled POLBOS 3 trial aimed to compare regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM C stent.
Topics: Acute Coronary Syndrome; Chromium; Cobalt; Coronary Stenosis; Drug-Eluting Stents; Humans; Multicenter Studies as Topic; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Research Design; Self Expandable Metallic Stents; Sirolimus; Treatment Outcome | 2019 |
Primary endpoint results of the OMEGA Study: One-year clinical outcomes after implantation of a novel platinum chromium bare metal stent.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Metals; Middle Aged; Patient Safety; Platinum; Prospective Studies; Prosthesis Design; Risk Assessment; Severity of Illness Index; Single-Blind Method; Stents; Survival Rate; Time Factors; Treatment Outcome | 2015 |
Fate of post-procedural malapposition of everolimus-eluting polymeric bioresorbable scaffold and everolimus-eluting cobalt chromium metallic stent in human coronary arteries: sequential assessment with optical coherence tomography in ABSORB Japan trial.
Topics: Absorbable Implants; Aged; Chromium; Cobalt; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Follow-Up Studies; Humans; Japan; Linear Models; Male; Metals; Middle Aged; Normal Distribution; Percutaneous Coronary Intervention; Postoperative Complications; Prospective Studies; Prosthesis Design; Prosthesis Failure; Risk Assessment; ROC Curve; Single-Blind Method; Tomography, Optical Coherence | 2018 |
Clinical and angiographic outcomes after treatment of de novo coronary stenoses with a novel platinum chromium thin-strut stent: primary results of the PERSEUS (Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXU
Topics: Aged; Chromium; Chromium Alloys; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paclitaxel; Platinum; Prospective Studies; Single-Blind Method; Treatment Outcome | 2010 |
The 'Harmonizing Optimal Strategy for Treatment of coronary artery stenosis - sAfety & effectiveneSS of drug-elUting stents & antiplatelet REgimen' (HOST-ASSURE) trial: study protocol for a randomized controlled trial.
Topics: Angioplasty, Balloon, Coronary; Chromium; Chromium Alloys; Coronary Stenosis; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Humans; Platelet Aggregation Inhibitors; Platinum; Prospective Studies; Prosthesis Design; Republic of Korea; Research Design; Single-Blind Method; Sirolimus; Time Factors; Treatment Outcome | 2012 |
13 other study(ies) available for chromium and Coronary Stenosis
| Article | Year |
|---|---|
Impact of Residual Stenosis on the Angiographic Edge Restenosis of a Second-Generation Drug-Eluting Stent.
Topics: Age Factors; Aged; Angioplasty, Balloon, Coronary; Chromium; Cobalt; Cohort Studies; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Equipment Failure Analysis; Female; Hospitals, University; Humans; Incidence; Japan; Logistic Models; Male; Middle Aged; Multivariate Analysis; Product Surveillance, Postmarketing; Prognosis; Prosthesis Design; Registries; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sex Factors; Sirolimus; Survival Analysis; Treatment Outcome | 2019 |
Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Topics: Aged; Aged, 80 and over; Cause of Death; Chromium; Cobalt; Comorbidity; Coronary Restenosis; Coronary Stenosis; Coronary Thrombosis; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Hemorrhage; Hemorrhagic Disorders; Humans; Kaplan-Meier Estimate; Male; Metabolic Syndrome; Middle Aged; Mortality; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Polymers; Prevalence; Proportional Hazards Models; Prospective Studies; Registries; Smoking; Treatment Outcome | 2020 |
First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C® - three-month results.
Topics: Acute Coronary Syndrome; Aged; Angina, Stable; Chromium; Cobalt; Coronary Stenosis; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Poland; Registries; Sirolimus; Treatment Outcome | 2018 |
Surrogate-based visualization and sensitivity analysis of coronary stent performance: A study on the influence of geometric design.
Topics: Alloys; Chromium; Computer Simulation; Coronary Stenosis; Elastic Modulus; Equipment Design; Finite Element Analysis; Humans; Percutaneous Coronary Intervention; Platinum; Stents; Tensile Strength | 2018 |
One-year outcomes in unselected patients treated with a thin-strut, platinum-chromium, paclitaxel-eluting stent: primary endpoint results from the TAXUS Element European post-approval surveillance study (TE-PROVE).
Topics: Aged; Cardiovascular Diseases; Chromium; Coronary Restenosis; Coronary Stenosis; Drug-Eluting Stents; Europe; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Paclitaxel; Percutaneous Coronary Intervention; Platinum; Product Surveillance, Postmarketing; Prospective Studies; Reoperation; Treatment Failure; Treatment Outcome; Tubulin Modulators | 2015 |
Unintentional extraction of a platinum-chromium everolimus-eluting stent by entanglement with a covered stent.
Topics: Aged; Chromium; Coronary Angiography; Coronary Stenosis; Device Removal; Drug-Eluting Stents; Everolimus; Humans; Immunosuppressive Agents; Male; Platinum; Vascular Calcification | 2016 |
A Novel Tram Stent Method in the Treatment of Coronary Bifurcation Lesions - Finite Element Study.
Topics: Angioplasty, Balloon, Coronary; Chromium; Cobalt; Coronary Angiography; Coronary Stenosis; Coronary Vessels; Finite Element Analysis; Heart; Humans; Stents; Treatment Outcome; Ultrasonography, Interventional | 2016 |
Biodegradable polymer-based, argatroban-eluting, cobalt-chromium stent (JF-04) for treatment of native coronary lesions: final results of the first-in-man study and lessons learned.
Topics: Absorbable Implants; Adult; Aged; Aged, 80 and over; Arginine; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Sulfonamides; Treatment Outcome | 2016 |
Three-month evaluation of strut healing using a novel optical coherence tomography analytical method following bioresorbable polymer everolimus-eluting stent implantation in humans: the TIMELESS study.
Topics: Absorbable Implants; Acute Coronary Syndrome; Aged; Cardiovascular Agents; Chromium; Coronary Angiography; Coronary Artery Disease; Coronary Stenosis; Coronary Vessels; Drug Therapy, Combination; Drug-Eluting Stents; Everolimus; Female; Humans; Lactic Acid; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Platinum; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Predictive Value of Tests; Prosthesis Design; Time Factors; Tomography, Optical Coherence; Treatment Outcome; Wound Healing | 2017 |
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses.
Topics: Aged; Angioplasty, Balloon, Coronary; Chromium; Coronary Angiography; Coronary Stenosis; Drug-Eluting Stents; Everolimus; Female; Humans; Male; Middle Aged; Platinum; Prospective Studies; Sirolimus; Ultrasonography, Interventional | 2011 |
A giant coronary aneurysm associated with a fractured cobalt-chromium stent.
Topics: Aged, 80 and over; Angioplasty, Balloon, Coronary; Calcinosis; Chromium; Cobalt; Coronary Aneurysm; Coronary Stenosis; Humans; Male; Prosthesis Failure; Stents | 2012 |
A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model.
Topics: Analysis of Variance; Animals; Carbon; Chromium; Coated Materials, Biocompatible; Cobalt; Coronary Angiography; Coronary Restenosis; Coronary Stenosis; Coronary Vessels; Disease Models, Animal; Drug Carriers; Drug Delivery Systems; Lactic Acid; Nanostructures; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Stents; Swine | 2006 |
Prospective registry evaluating safety and efficacy of cobalt-chromium stent implantation in patients with de novo coronary lesions.
Topics: Aged; Angioplasty, Balloon, Coronary; Biocompatible Materials; Chromium; Cobalt; Coronary Artery Disease; Coronary Stenosis; Female; Follow-Up Studies; Humans; Male; Middle Aged; Registries; Stents; Time Factors; Treatment Outcome | 2007 |